Price (GBX)
181.00 -2.69% (-5.00)
AVCTORD 10P
Track 1 instrument
Open / Last close
- / 186.00
High / Low
186.50 / 176.00
Bid / Offer
179.00 / 183.00
Turnover
£18,585.00
Special Condition: -
Trading Status: Regular Trading
As at 21.10.20 14:26:39 - All data delayed at least 15 minutes

Avacta Group PLC instruments

Select instrument to view
Equity (1)
Code Instrument name Price Change Type Documentation
AVCTORD 10P181.00
GBX
-2.69%Equity-

Price information

What's this?
Open price
-
Previous close price / date
186.00 / 20 October 2020
Volume
1,393,306
Turnover
£18,585.00
52 week range
14.00 / 202.00
YTD return
905.41
1 year return
1,053.49

Instrument information

What's this?
Market
AIM
Instrument market cap (£m)
469.93
Earnings per share
-0.13
Issue date
26 January 2016
ISIN
GB00BYYW9G87
SEDOL
BYYW9G8
Market identifier code (MIC)
AIMX
Country of share register
GB
Market segment
ASX1
Trading service
SETSqx
Nominated Advisers
Date Time Price CurrencyVolume Trade ValueTrade type Trade flag MIC
21.10.20 13:37:07 181.90 GBX 8,000 14,552.00 Off-Book LRGS AIMX
21.10.20 14:21:55 181.65 GBX 546 991.81 Off-Book - AIMX
21.10.20 14:18:10 180.10 GBX 1,995 3,593.00 Off-Book - AIMX
21.10.20 14:16:26 180.10 GBX 3,513 6,326.91 Off-Book - AIMX
21.10.20 14:16:25 181.65 GBX 550 999.08 Off-Book - AIMX

Equity Research

from Avacta Group PLC
SP Angel Healthcare Conditions

Avacta (AVCT.L): Adeptrix COVID-19 Diagnostic Test update | Diaceutics (DXRX.L): New contract win

View report
SP Angel Healthcare Conditions

Novacyt (NCYT.L): Trading update | Avacta (AVCT.L): COVID-19 wastewater detection sensor collaboration with Integumen

View report
Morning Note – 24 June 2020

Allergy Therapeutics (AGY.L): Corp Profit upgrade | Aukett Swanke (AUK.L): Corp Interim results | Avacta (AVTG.L): Corp SARS-CoV-2 point-of care antigen test – update | discoverIE (DSCV.L): Corp Resilient, flexible and well positioned for growthiomart (IOMG.L): Corp Finals to ...

View report
Morning Note – 18 June 2020

Access Intelligence (ACCI.L): Corp Half-year trading update | Avacta (AVTG.L): Corp Potential COVID-19 therapeutic – progress | Synairgen (SNG): Corp COVID-19 home setting trial amendments | Tremor (TRMR): Corp Strong Q1 before large COVID-19 impacts in Q2

View report
Morning Note – 9 June 2020

Avacta (AVTG.L): Corp | Europa Oil & Gas (EOG): Corp | Omega Diagnostics (ODX): Corp | Redcentric (RCN): Corp | Telit (TCM): Corp

View report

Latest reports

from Avacta Group PLC
Avacta Annual Report and Accounts 2019
file

Contacts

from Avacta Group PLC
Avacta's PR agency
Yellow Jersey PR
atAvacta Group PLC
+44 (0)20 3004 9512.
avacta@yellowjerseypr.com
Issuer presentations live and on demand
Watch on Spark Live